Evidence map›Paper›PMID 32601248›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis.

Jessica Stupack, Xiao-Peng Xiong, Lu-Lin Jiang, Tongmei Zhang, Lisa Zhou, Alex Campos, Barbara Ranscht, William Mobley, Elena B Pasquale, Huaxi Xu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Silencing the enhancer of zeste homologue 2,Neural regeneration research · 2022
    Article
  13. Article
  14. MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jessica StupackNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.
Xiao-Peng XiongNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.
Lu-Lin JiangNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.ORCID 0000-0003-4527-3662
Tongmei ZhangNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.
Lisa ZhouNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.
Alex CamposProteomics Facility Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.
Barbara RanschtNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.
William MobleyDepartment of Neurosciences, University of California San Diego, La Jolla, California 92093.
Elena B PasqualeNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037.ORCID 0000-0002-5076-4848
Huaxi XuNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037 thuang@sbpdiscovery.org xuh@sbpdiscovery.org.ORCID 0000-0001-7031-7853
Timothy Y HuangNeuroscience Initiative, and Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037 thuang@sbpdiscovery.org xuh@sbpdiscovery.org.ORCID 0000-0002-3504-9459
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of California San Diego · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Regulation of Protein Trafficking in NeurodegenerationR01NS046673 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI XU, HUAXI · 2003 to 2018
$5.8M
Cyclic EphA4 peptide antagonists for neuroprotection in ALSR01NS087070 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PASQUALE, ELENA B · 2014 to 2018
$3.5M
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in ADR01AG061875 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HUANG, TIMOTHY YIKAI · 2018 to 2022
$3.4M
Discovery of Selective Inhibitors for the EphA4 KinaseR01AG062617 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PASQUALE, ELENA B, SERGIENKO, EDUARD A. · 2020 to 2023
$3.0M
Characterizing neuroprotective roles for SNX27 signaling pathways in AD and DSRF1AG044420 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HUANG, TIMOTHY YIKAI · 2018 to 2018
$2.4M
Roles of SN27 in regulating glutamate receptors during neurodegenerationR01AG044420 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI XU, HUAXI · 2013 to 2017
$2.0M
NCI NIH HHS P30 CA030199NIA NIH HHS R01 AG044420NIA NIH HHS R01 AG061875NIA NIH HHS R01 AG062617NIA NIH HHS RF1 AG044420NINDS NIH HHS R01 NS046673NINDS NIH HHS R01 NS087070
6 · The paper itself

Abstract

SORLA is a transmembrane trafficking protein associated with Alzheimer's disease risk. Although SORLA is abundantly expressed in neurons, physiological roles for SORLA remain unclear. Here, we show that cultured transgenic neurons overexpressing SORLA feature longer neurites, and accelerated neurite regeneration with wounding. Enhanced release of a soluble form of SORLA (sSORLA) is observed in transgenic mouse neurons overexpressing human SORLA, while purified sSORLA promotes neurite extension and regeneration. Phosphoproteomic analyses demonstrate enrichment of phosphoproteins related to the epidermal growth factor (EGFR)/ERK pathway in SORLA transgenic mouse hippocampus from both genders. sSORLA coprecipitates with EGFR

Indexed as

AnimalsCells, CulturedErbB ReceptorsFemaleGene Expression RegulationGenes, fosHippocampusMaleMAP Kinase Signaling SystemMembrane Transport ProteinsMiceMice, Inbred BALB CMice, TransgenicNerve RegenerationNeuritesPhosphorylationErbB ReceptorsMembrane Transport ProteinsReceptors, LDLSorl1 protein, mouseEGF receptorERKneurite outgrowthneurite regenerationsoluble SORLASORLA

Identifiers

PMID32601248
PMCPMC7392511
OpenAlexW3038377734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.